A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours

BACKGROUND: There is an urgent need for biomarkers for the early detection of ovarian cancer (OC). The purpose of this study was to assess whether changes in serum levels of lecithin-cholesterol acyltransferase (LCAT), sex hormone-binding globulin (SHBG), glucose-regulated protein, 78 kDa (GRP78), c...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Matthew R, Graham, Ciaren, D'Amato, Alfonsina, Gentry-Maharaj, Aleksandra, Ryan, Andy, Kalsi, Jatinderpal K, Ainley, Carol, Whetton, Anthony D, Menon, Usha, Jacobs, Ian, Graham, Robert L J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572165/
https://www.ncbi.nlm.nih.gov/pubmed/28664912
http://dx.doi.org/10.1038/bjc.2017.199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572165/
https://www.ncbi.nlm.nih.gov/pubmed/28664912
http://dx.doi.org/10.1038/bjc.2017.199

Ejemplares similares